SQZ Biotechnologies Announces First Data Presentation on Non-Clinical Studies of Point-of-Care Manufacturing System and Collaboration with STEMCELL Technologies on Research-Use-Only System to Fuel Preclinical Research Read More
Expand Your Delivery Universe with the Cell Squeeze® Technology
Broadening Access to a New Generation of Cell Engineering
We believe in expanding the therapeutic breadth and accessibility of cell therapies to transform patient care. An important element of our vision is to facilitate the next wave of research advancements by offering unique cell engineering capabilities to the life sciences community. In collaboration with STEMCELL Technologies, we plan to co-develop and commercialize a research-use-only (RUO) system, which incorporates our proven proprietary Cell Squeeze® technology for versatile intracellular delivery at preclinical research scale.
SQZ’s Cell Squeeze ® technology has enabled the development of three oncology therapeutic candidates in active Phase 1/2 clinical trials.
The RUO System
Our benchtop RUO system is designed for efficient, gentle, and vector-free delivery of cargoes to a range of primary cell types – all with a workflow that can be integrated into cell therapy research.
Our publications: Learn about how we engineer cells for therapeutic impact 
Cell engineering with the RUO system:
Efficient delivery of mRNA and Cas9 RNP to NK and T cells with minimal perturbations
Connect with Us to Learn More
Sign up to receive updates on the research-use-only (RUO) system for intracellular delivery that is currently under development in collaboration with STEMCELL Technologies. Sign up
Interested in translational applications with the Cell Squeeze® platform? Fill out the form below to connect with us.